JP Morgan Chase’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.5M | Sell |
27,500
-29,100
| -51% | -$14.7M | ﹤0.01% | 2479 |
|
|
2025
Q4 | $32.1M | Buy |
56,600
+4,400
| +8% | +$2.34M | ﹤0.01% | 1671 |
|
|
2025
Q3 | $23.3M | Buy |
52,200
+19,300
| +59% | +$9.26M | ﹤0.01% | 1971 |
|
|
2025
Q2 | $17.9M | Buy |
32,900
+27,900
| +558% | +$14.6M | ﹤0.01% | 2033 |
|
|
2025
Q1 | $2.48M | Sell |
5,000
-28,400
| -85% | -$15.7M | ﹤0.01% | 3714 |
|
|
2024
Q4 | $17.4M | Sell |
33,400
-2,400
| -7% | -$1.25M | ﹤0.01% | 2169 |
|
|
2024
Q3 | $17.6M | Buy |
35,800
+1,400
| +4% | +$652K | ﹤0.01% | 2107 |
|
|
2024
Q2 | $15.3M | Buy |
34,400
+2,300
| +7% | +$916K | ﹤0.01% | 2083 |
|
|
2024
Q1 | $12.8M | Sell |
32,100
-114,300
| -78% | -$43.2M | ﹤0.01% | 2263 |
|
|
2023
Q4 | $49.4M | Buy |
146,400
+106,900
| +271% | +$31.9M | ﹤0.01% | 1223 |
|
|
2023
Q3 | $11.5M | Buy |
39,500
+1,100
| +3% | +$344K | ﹤0.01% | 2132 |
|
|
2023
Q2 | $13.1M | Buy |
38,400
+30,500
| +386% | +$9.23M | ﹤0.01% | 2050 |
|
|
2023
Q1 | $2.02M | Sell |
7,900
-40,600
| -84% | -$10M | ﹤0.01% | 3536 |
|
|
2022
Q4 | $12.9M | Buy |
48,500
+8,600
| +22% | +$2.1M | ﹤0.01% | 2036 |
|
|
2022
Q3 | $7.48M | Sell |
39,900
-4,300
| -10% | -$924K | ﹤0.01% | 2397 |
|
|
2022
Q2 | $8.87M | Buy |
44,200
+4,800
| +12% | +$1.13M | ﹤0.01% | 2270 |
|
|
2022
Q1 | $11.9M | Sell |
39,400
-35,600
| -47% | -$10.4M | ﹤0.01% | 2197 |
|
|
2021
Q4 | $26.9M | Hold |
75,000
| – | – | ﹤0.01% | 1576 |
|
|
2021
Q3 | $24.9M | Hold |
75,000
| – | – | ﹤0.01% | 1590 |
|
|
2021
Q2 | $23M | Buy |
75,000
+69,300
| +1,216% | +$19.4M | ﹤0.01% | 1723 |
|
|
2021
Q1 | $1.4M | Sell |
5,700
-41,100
| -88% | -$10.3M | ﹤0.01% | 3967 |
|
|
2020
Q4 | $12.8M | Sell |
46,800
-24,300
| -34% | -$6.03M | ﹤0.01% | 2007 |
|
|
2020
Q3 | $16.4M | Buy |
71,100
+18,600
| +35% | +$4.18M | ﹤0.01% | 1631 |
|
|
2020
Q2 | $9.97M | Sell |
52,500
-120,000
| -70% | -$21.5M | ﹤0.01% | 1898 |
|
|
2020
Q1 | $28.5M | Buy |
172,500
+61,800
| +56% | +$11.3M | 0.01% | 1058 |
|
|
2019
Q4 | $21.8M | Buy |
110,700
+108,900
| +6,050% | +$20.4M | ﹤0.01% | 1522 |
|
|
2019
Q3 | $324K | Hold |
1,800
| – | – | ﹤0.01% | 4388 |
|
|
2019
Q2 | $311K | Hold |
1,800
| – | – | ﹤0.01% | 4463 |
|
|
2019
Q1 | $342K | Sell |
1,800
-32,700
| -95% | -$5.81M | ﹤0.01% | 4386 |
|
|
2018
Q4 | $5.51M | Buy |
34,500
+6,000
| +21% | +$1.02M | ﹤0.01% | 2499 |
|
|
2018
Q3 | $5.45M | Buy |
28,500
+1,500
| +6% | +$266K | ﹤0.01% | 2677 |
|
|
2018
Q2 | $4.31M | Hold |
27,000
| – | – | ﹤0.01% | 2805 |
|
|
2018
Q1 | $3.71M | Hold |
27,000
| – | – | ﹤0.01% | 2825 |
|
|
2017
Q4 | $3.28M | Buy |
27,000
+3,600
| +15% | +$451K | ﹤0.01% | 3000 |
|
|
2017
Q3 | $2.67M | Hold |
23,400
| – | – | ﹤0.01% | 2987 |
|
|
2017
Q2 | $2.43M | Buy |
+23,400
| New | +$2.25M | ﹤0.01% | 2926 |
|
Other funds holding ISRG
VCM
VPM
JP Morgan Chase's ISRG Position: Q1 2026 in Review
JP Morgan Chase increased its Intuitive Surgical (ISRG) stake by 13% in Q1 2026, buying an estimated $260M and bringing the position to 4,593,894 shares worth $2.08B. The position accounts for 0.13% of the portfolio, ranked #155.
JP Morgan Chase first reported a position in ISRG in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.3B in Q4 2024. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.
- JP Morgan Chase held 4,593,894 shares of Intuitive Surgical worth $2.08B as of Q1 2026.
- JP Morgan Chase bought 513,014 Intuitive Surgical shares in Q1 2026, an estimated $260M.
- Intuitive Surgical made up 0.13% of JP Morgan Chase's portfolio in Q1 2026, its #155 holding.
- JP Morgan Chase first reported a position in Intuitive Surgical in Q2 2013 and has held it in 52 quarters since.
- JP Morgan Chase's Intuitive Surgical position peaked at $5.3B in Q4 2024.
- 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.